Answers are grounded in this paper and cite their sources.
Background: Novel urinary biomarkers have always remained/continue to remain a fascinating area of exploration in the domain of modern nephrology. They are promisingly convincing in obviating the major disadvantages of creatinine in the setting of Acute Kidney Injury (AKI). The specific novel tubular markers include Neutrophil Gelatinase Associated Lipocalin (NGAL), Interleukin-18 (IL-18), Kidney Injury Molecule-1 (KIM-1), Hepatocyte growth factor, Osteopontin and Fatty acid binding proteins.
No takes yet. Share an insight, caveat, or question.
Jayaraman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: